# Cerenome, Inc.: filings

CNSY · Nasdaq · CIK 1095981 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cnsy.md) · [Financials](/companies/cnsy/financials.md) · [Filings](/companies/cnsy/filings.md) · [Insiders](/companies/cnsy/insiders.md)

## Reports and events: 425 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 363, 8-K 292, 10-Q 53, CORRESP 32, UPLOAD 32, SC 13G/A 28, EFFECT 27, 424B3 26, 3 25, 424B5 21, DEF 14A 20, 10-K 18, SC 13G 18, S-1 17, 4/A 13, S-3 12, PRE 14A 11, S-1/A 10, 10-K/A 8, S-8 8, DEFA14A 7, 424B4 6, ARS 6, FWP 6, S-3/A 6, CT ORDER 5, SCHEDULE 13G/A 5, RW 4, SCHEDULE 13G 4, SD 4, 25-NSE 3, 8-A12B 3, D 3, DRS 3, 10-Q/A 2, 8-K/A 2, CERTNAS 2, NT 10-Q 2, POS AM 2, S-1MEF 2, SC 13D/A 2, 144 1, 5 1, CERT 1, PRER14A 1, S-3MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 11:30 ET | [8-K](/filings/0001193125-26-411259.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-411259 |
| 2026-09-10 | 12:01 ET | [8-K](/filings/0001193125-26-387267.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-387267 |
| 2026-08-14 | 20:35 ET | [10-Q](/filings/0001193125-26-352444.md) | Quarterly report, period 2026-06-30 | 0001193125-26-352444 |
| 2026-08-14 | 20:21 ET | [8-K](/filings/0001193125-26-352346.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-352346 |
| 2026-08-04 | 20:30 ET | [8-K](/filings/0001193125-26-332939.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-332939 |
| 2026-06-05 | 20:30 ET | [8-K](/filings/0001193125-26-259703.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-259703 |
| 2026-05-15 | 20:46 ET | [8-K](/filings/0001193125-26-227059.md) | 5.07 Shareholder vote results | 0001193125-26-227059 |
| 2026-05-15 | 20:33 ET | [10-Q](/filings/0001193125-26-226978.md) | Quarterly report, period 2026-03-31 | 0001193125-26-226978 |
| 2026-05-15 | 20:13 ET | [8-K](/filings/0001193125-26-226747.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-226747 |
| 2026-04-21 | 12:30 ET | [8-K](/filings/0001193125-26-165205.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-165205 |
| 2026-04-09 | 12:01 ET | [8-K](/filings/0001193125-26-148920.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-148920 |
| 2026-04-08 | 11:30 ET | [8-K](/filings/0001193125-26-146335.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-146335 |
| 2026-04-02 | 20:30 ET | [8-K](/filings/0001193125-26-140267.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-140267 |
| 2026-03-31 | 20:20 ET | [DEF 14A](/filings/0001193125-26-134646.md) | Proxy statement, period 2026-05-14 | 0001193125-26-134646 |
| 2026-03-26 | 12:33 ET | [8-K](/filings/0001193125-26-125195.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-125195 |
| 2026-03-12 | 20:35 ET | [8-K](/filings/0001193125-26-104291.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-104291 |
| 2026-03-12 | 20:29 ET | [10-K](/filings/0001193125-26-104258.md) | Annual report, period 2025-12-31 | 0001193125-26-104258 |
| 2026-03-12 | 20:21 ET | [8-K](/filings/0001193125-26-104218.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104218 |
| 2026-02-13 | 21:09 ET | [8-K](/filings/0001193125-26-051379.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-051379 |
| 2026-01-22 | 12:30 ET | [8-K](/filings/0001193125-26-018675.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-018675 |
| 2026-01-16 | 21:05 ET | [8-K](/filings/0001193125-26-015346.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-015346 |
| 2026-01-09 | 21:10 ET | [S-1](/filings/0001193125-26-008922.md) | Registration statement | 0001193125-26-008922 |
| 2025-11-17 | 12:35 ET | [8-K](/filings/0001193125-25-283935.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-283935 |
| 2025-10-30 | 20:20 ET | [10-Q](/filings/0001193125-25-258596.md) | Quarterly report, period 2025-09-30 | 0001193125-25-258596 |
| 2025-10-30 | 20:15 ET | [8-K](/filings/0001193125-25-258568.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-258568 |
| 2025-10-21 | 11:25 ET | [8-K](/filings/0001193125-25-244275.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-244275 |
| 2025-08-26 | 10:30 ET | [8-K](/filings/0001193125-25-188075.md) | 8.01 Other events | 0001193125-25-188075 |
| 2025-08-14 | 20:27 ET | [8-K](/filings/0001193125-25-180814.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-180814 |
| 2025-08-14 | 20:12 ET | [10-Q](/filings/0000950170-25-108874.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108874 |
| 2025-08-14 | 20:07 ET | [8-K](/filings/0000950170-25-108854.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108854 |
| 2025-08-13 | 10:04 ET | [8-K](/filings/0001193125-25-179382.md) | 8.01 Other events | 0001193125-25-179382 |
| 2025-08-12 | 20:31 ET | [8-K](/filings/0001193125-25-179012.md) | 5.07 Shareholder vote results | 0001193125-25-179012 |
| 2025-08-12 | 20:06 ET | [S-1](/filings/0001193125-25-178940.md) | Registration statement | 0001193125-25-178940 |
| 2025-07-21 | 20:05 ET | [DEF 14A](/filings/0001140361-25-026611.md) | Proxy statement, period 2025-08-07 | 0001140361-25-026611 |
| 2025-07-18 | 20:30 ET | [8-K](/filings/0001193125-25-161239.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-25-161239 |
| 2025-06-20 | 20:16 ET | [8-K](/filings/0001193125-25-143665.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-143665 |
| 2025-06-20 | 01:51 ET | [S-1/A](/filings/0001193125-25-142935.md) | Registration statement, amended | 0001193125-25-142935 |
| 2025-06-18 | 01:21 ET | [S-1](/filings/0001193125-25-142215.md) | Registration statement | 0001193125-25-142215 |
| 2025-06-17 | 20:25 ET | [8-K](/filings/0001193125-25-142093.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-142093 |
| 2025-06-06 | 20:22 ET | [8-K](/filings/0001193125-25-137089.md) | 3.01 Delisting notice | 0001193125-25-137089 |
| 2025-05-30 | 20:20 ET | [8-K](/filings/0000950170-25-079749.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-079749 |
| 2025-05-30 | 20:15 ET | [10-Q](/filings/0000950170-25-079738.md) | Quarterly report, period 2025-03-31 | 0000950170-25-079738 |
| 2025-05-23 | 20:22 ET | [8-K](/filings/0001193125-25-125860.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-125860 |
| 2025-05-19 | 20:20 ET | [8-K](/filings/0000950170-25-074374.md) | 3.01 Delisting notice | 0000950170-25-074374 |
| 2025-05-02 | 20:05 ET | [8-K](/filings/0000950170-25-062742.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-062742 |
| 2025-04-30 | 20:05 ET | [10-K/A](/filings/0000950170-25-061028.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-061028 |
| 2025-04-18 | 20:30 ET | [8-K](/filings/0000950170-25-055883.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-055883 |
| 2025-04-10 | 20:11 ET | [DEF 14A](/filings/0001140361-25-013256.md) | Proxy statement, period 2025-05-02 | 0001140361-25-013256 |
| 2025-03-31 | 20:06 ET | [10-K](/filings/0000950170-25-047698.md) | Annual report, period 2024-12-31 | 0000950170-25-047698 |
| 2025-03-27 | 20:24 ET | [8-K](/filings/0000950170-25-046110.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046110 |

Page 1 of 9. [Older](/companies/cnsy/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.